Spontaneous endogenous pulsatile release of kisspeptin is temporally coupled with luteinizing hormone in healthy women

Sunday, May 1, 2016
Measuring the plasma concentrations of kisspeptin, this study reveals groundbreaking evidence suggesting that kisspeptin and luteinizing hormone are cosecreted and temporally coupled in healthy women.

Read More

Diminished ovarian reserve in the United States assisted reproductive technology population Diagnostic trends among 181536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System

Tuesday, September 1, 2015
Diminished ovarian reserve (DOR) assignment increased 7% among all Society for Assisted Reproductive Technology Clinic Outcomes Reporting System cycles from 2004 to 2011, despite minimal increase in patient age at cycle start. The ability of DOR assignment to predict poor ovarian response worsened.

Read More

What to do when the numbers dont add up

Wednesday, April 29, 2015
Reflections on "Does antral follicle count (AFC) predict pregnancy rates in unstimulated therapeutic donor insemination (TDI) cycles?" by Ripley et al.

Read More

Unraveling the fertility knot in World Health Organization type 2 anovulatory women Another step toward a pharmacogenetic treatment choice

Monday, March 30, 2015
Reflections on "FSH receptor polymorphism affects the outcome of ovulation induction in normogonadotropic (WHO2) anovulatory infertility" by Valkenburg et al.

Read More

Effect of ABO blood type on ovarian reserve in Chinese women

Tuesday, November 25, 2014
Women with blood type O had a reduced likelihood of diminished ovarian reserve, but women with blood type B or AB had an increased risk.

Read More

Female age related fertility decline

Thursday, February 20, 2014
Education and enhanced awareness of the effect of age on fertility is essential in counseling the patient who desires pregnancy.

Read More

Association of blood type and patient characteristics with ovarian reserve

Wednesday, November 27, 2013
No relationship could be demonstrated between blood type and risk of diminished ovarian reserve in an analysis of 305 patients undertaking in vitro fertilization.

Read More

FSHB 211 and FSHR 2039 are associated with serum levels of follicle stimulating hormone and antimüllerian hormone in healthy girls a longitudinal cohort study

Monday, September 30, 2013
FSHB GG+FSHR AA is the most favorable genotype for male gonadal function, but it has never been evaluated in girls. Healthy girls with this genotype have increased follicle-stimulating hormone and reduced antimüllerian hormone.

Read More

Why we may abandon basal follicle stimulating hormone testing A sea change in determining ovarian reserve using antimüllerian hormone

Friday, May 31, 2013
Antimullerian hormone is a more informative and therefore a better serum test of ovarian reserve than basal FSH.

Read More

Use of antimüllerian hormone the risks of interpreting ovarian reserve markers in isolation

Friday, May 31, 2013
Reflections on "Why we may abandon basal follicle-stimulating hormone testing: A sea change in determining ovarian reserve using antimullerian hormone" by Toner et al.

Read More

Antimüllerian hormone levels decrease in women using combined contraception independently of administration route

Thursday, March 28, 2013
In young healthy, normal weight women, continuous use of combined contraception leads to a decrease in serum AMH levels independently of administration route.

Read More

Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization

Monday, March 18, 2013
Some genetic polymorphisms are associated with ovarian response to gonadotropin administration and exhibit potential for a pharmacogenetic approach in ovarian stimulation. In contrast, ovarian reserve seems to be independent of gonadotropin variants.

Read More

Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth…

Thursday, September 27, 2012
Adding recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment protocols in adolescent/young adult men with hypogonadotropic hypogonadism results in normal testicular growth and may hasten induction of spermatogenesis.

Read More

High frequency of discordance between antimullerian hormone and follicle stimulating hormone levels in serum from estradiol confirmed days 2 to 4 of the menstrual cycle from 5354 women in US…

Thursday, September 27, 2012
Frequent discordance was observed between antimullerian hormone and follicle-stimulating hormone, which increased with age in serum from 5,354 women in estradiol-confirmed cycle days 2 to 4.

Read More

Role of FSH to optimize adolescent testicular growth

Thursday, September 27, 2012
Reflections on "Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis"

Read More

Does ovulation induction with follicle-stimulating hormone still have a future in polycystic ovary syndrome?

Friday, June 8, 2012

Author:
Robert John Norman, M.D.…

Read More

A characterization of the relationship of ovarian reserve markers with age

Monday, June 4, 2012
Antral follicle count and antimullerian hormone rate of decline is similar to histologic oocyte loss.

Read More

Impact of infertility regimens on breast cancer cells: follicle-stimulating hormone and luteinizing hormone lack a direct effect on breast cell proliferation in vitro

Tuesday, May 29, 2012
Treatment of cultured normal and malignant breast cells with follicle-stimulating hormone, luteinizing hormone, and human chorionic gonadotropin did not result in cell proliferation or growth.

Read More

Can FSH co-trigger prevent OHSS?

Tuesday, May 22, 2012
FSH co-trigger after ovarian stimulation has been shown to improve oocyte competence and a recent report suggested that the FSH co-trigger can completely prevent OHSS.

Read More

Translate »